Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are the six latest drugs or medical devices approved by the Food and Drug Administration.
The Food and Drug Administration recently approved Intrarosa as a treatment for women who experience dyspareunia, or moderate to severe pain during sexual intercourse.
Somerset, N.J.-based Gavis Pharmaceuticals — a subsidiary of Mumbai-based Lupin Limited — recently earned approval from the Food and Drug Administration for its hydrocodone bitartrate and acetaminophen tablets.
Online retail giant Amazon filed two lawsuits this week against sellers, claiming they put counterfeit goods on its website, reports The Wall Street Journal.
A new study highlights a large variance in the cost of generic heart failure medications in the St. Louis area, causing some uninsured patients to struggle with drugs' affordability, reports Reuters.
This season of thanksgiving brings a timely opportunity to recognize the integral – and, often, understated – role that healthcare supply chain professionals play, and to champion their shared commitment to the advancement of a safe, effective and efficient healthcare…
Rebecca Hellmann, Vice President of Marketing, Hospital Solutions & Global Supply Chain, Cardinal Health
A fire broke out last weekend in one of Amazon's distribution center in the U.K., forcing several retailers to remove their products from the company's website, according to Business Insider.
At the request of the Food and Drug Administration, Leverkusen, Germany-based Bayer will now add a box warning and patient decision checklist to the label of its permanent birth control device Essure.
The most effective way to manage purchasing compliance is to ensure requestors see the products supply chain leaders have negotiated the best prices for, according to Michael DeLuca, executive vice president of technology and client services for Cranberry Township, Pa.-based…
Basel, Switzerland-based Novartis may sell its eye care business Alcon, reports Reuters.